Resuming specific medications following a surgical procedure requires careful consideration and personalized medical advice. The timing of restarting a glucagon-like peptide-1 (GLP-1) receptor agonist, such as tirzepatide (brand name Mounjaro), post-operatively depends on several factors, including the type of surgery, the patient’s overall health, and the specific instructions provided by the surgical team and endocrinologist. Typically, such medications might be temporarily discontinued before surgery to minimize potential gastrointestinal side effects like nausea and vomiting.
Careful management of blood glucose levels is crucial for surgical patients, both for wound healing and overall recovery. Resuming appropriate glucose-lowering therapies, when medically indicated, plays a significant role in preventing post-surgical complications associated with hyperglycemia. The appropriate timing of restarting these medications contributes to a patient’s well-being and a smoother recovery process. Consulting with the prescribing physician allows for a tailored approach, taking into account the individual’s specific surgical context and metabolic needs.
